Laboratory measures of coagulation among patients on novel oral anticoagulants
| Dabigatran | Rivaroxaban | Apixaban | P values | |
| n | 50 | 123 | 34 | |
| PT value (IQR) | 14.1 (12.1–15.5) | 13.8 (11.8–17.3) | 13.4 (11.3–15) | 0.4406 |
| INR (IQR) | 1.3 (1.1–1.4) | 1.3 (1.1–1.6) | 1.1 (1.0– 1.2) | 0.0113 |
| aPTT (IQR) | 35.0 (29.8– 46.3) | 30.4 (27.0–35.9) | 28.7 (25.7–33.9) | 0.0017 |
| TEG R median (IQR) | 5.3 (3.9–7.5) | 5.6 (4.4–8.0) | 4.4 (4.0–5.0) | 0.2066 |
| TEG alpha median (IQR) | 69.5 (67.6–72.6) | 70.7 (65.7–73.8) | 71.2 (65.6–76.4) | 0.8729 |
| TEG MA median (IQR) | 66.8 (62.9–69.8) | 67.3 (62.2–71.0) | 67.1 (62.4–72.5) | 0.9860 |
Significant values in bold. Normal values: PT=9.7–12.5; aPTT=25–34; R=5–10; alpha=53–72; MA=50–70; lysis=0%–8%.
INR, international normalized ratio; TEG, thromboelastography.